List of Studies ( Metabolite:LacCer 18:1;O2/26:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST001877 | AN003080 | Targeted Sphingolipid analysis of HeLa knockout for expression of GRASP55 | HeLa cells | Human | IBBC, CNR | LC-MS | |
| ST001673 | AN002731 | Targeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS | HeLa cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST001672 | AN002730 | Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 | Fibroblast cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST000004 | AN000006 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |